Evert-Jan ter Borg - JoVE Visualize

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Clinical and Experimental Rheumatology|October 18, 2016

Necessity of TNF-alpha inhibitor discontinuation in rheumatoid arthritis is predicted by smoking and number of previously used biological DMARDsBart V J Cuppen, Johannes W G Jacobs, Evert-Jan Ter Borg, et al.

Arthritis and Rheumatism|July 9, 2003

Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first yearSuzan M M Verstappen, Johannes W G Jacobs, Johannes W J Bijlsma, et al.

The Journal of Rheumatology|October 18, 2011

Look beyond the disease activity score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritisEvelien Ton, Marije F Bakker, Suzanne M M Verstappen, et al.

Annals of the Rheumatic Diseases|June 15, 2019

Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trialsMaxime Ma Verhoeven, Marjolein Jh de Hair, Janneke Tekstra, et al.

Lancet (London, England)|June 12, 2016

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trialJohannes W J Bijlsma, Paco M J Welsing, Thasia G Woodworth, et al.

Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Clinical and Experimental Rheumatology|October 18, 2016

Necessity of TNF-alpha inhibitor discontinuation in rheumatoid arthritis is predicted by smoking and number of previously used biological DMARDsBart V J Cuppen, Johannes W G Jacobs, Evert-Jan Ter Borg, et al.

Arthritis and Rheumatism|July 9, 2003

Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first yearSuzan M M Verstappen, Johannes W G Jacobs, Johannes W J Bijlsma, et al.

The Journal of Rheumatology|October 18, 2011

Look beyond the disease activity score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritisEvelien Ton, Marije F Bakker, Suzanne M M Verstappen, et al.

Annals of the Rheumatic Diseases|June 15, 2019

Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trialsMaxime Ma Verhoeven, Marjolein Jh de Hair, Janneke Tekstra, et al.

Lancet (London, England)|June 12, 2016

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trialJohannes W J Bijlsma, Paco M J Welsing, Thasia G Woodworth, et al.

Pageof 2